BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Harvard Law and International Development Society - ECPv6.15.0//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://orgs.law.harvard.edu/lids
X-WR-CALDESC:Events for Harvard Law and International Development Society
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20130310T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20131103T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20130916T120000
DTEND;TZID=America/New_York:20130916T130000
DTSTAMP:20260418T014759
CREATED:20130907T025947Z
LAST-MODIFIED:20130907T025947Z
UID:1954-1379332800-1379336400@orgs.law.harvard.edu
SUMMARY:International Student Organizations Info Session
DESCRIPTION:
URL:https://orgs.law.harvard.edu/lids/event/international-student-organizations-info-session/
LOCATION:MA
CATEGORIES:Joint Event
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20130916T120000
DTEND;TZID=America/New_York:20130916T130000
DTSTAMP:20260418T014759
CREATED:20130907T024424Z
LAST-MODIFIED:20130907T030251Z
UID:1950-1379332800-1379336400@orgs.law.harvard.edu
SUMMARY:Compulsory License and Access to Medicines: The Indian Experience To Date
DESCRIPTION:Event Date:  Monday\, Sept. 16\, 2013  \nEvent Time:  12:00-1:00 p.m. \nEvent Location:  Wasserstein Hall Room B015\,  Harvard Law School \n\n \nDescription: \nMr. V. Lakshmikumaran is the founder and managing partner of Lakshmikumaran & Sridharan (L&S).  L&S is one of India’s elite law firms\, serving several Fortune 500 and top Indian companies in international trade\, tax\, intellectual property\, and corporate matters.   Chambers Asia Pacific recently declared several L&S’s practices to be in the top-tier and  exclaimed that Mr. Lakshmikumaran “possesses a virtual monopoly when it comes to indirect tax litigation” in India.  Besides corporate and tax matters\, L&S handles high-profile intellectual property (IP) cases and has been retained by the Indian government to argue several cases on its behalf before the World Trade Organization (WTO). \nMr. Lakshmikumaran’s talk will focus on India’s compulsory licensing regime\, which can be used to mandate that an IP holder license its IP right to another company or individual for a fee.  In 2012\, India’s government first exercised its power to issue a compulsory license\, allowing a generic pharmaceutical company\, Natco\, to manufacture a version of the cancer-fighting drug\, Nexavar\, developed by Bayer\, after finding\, among others\, the branded drug to be cost-prohibitive for India.  This action is being closely watched worldwide because of the important role played by Indian companies in supplying affordable generic versions of medicines globally.  In March 2013\, the Indian Patent Appeals Body rejected an appeal from Bayer; the case is now before the High Court of Bombay.  If upheld\, the development of this regime may be a game changer for global health\, opening the way for other Indian generic pharmaceutical companies to seek compulsory licenses to manufacture cheaper version of essential drugs.  In fact\, further applications have already been filed against Bristol-Meyers Squibb and Roche for other cancer-fighting drugs.  Mr. Lakshmikumaran will discuss recent global trends in compulsory licensing\, examine the Indian legal framework\, and discuss the lessons of the Nexavar dispute.  He will also explore the compatibility of India’s compulsory licensing regime with the WTO’s TRIPS Agreement. \nLIDS will be co-hosting this event.
URL:https://orgs.law.harvard.edu/lids/event/lids-co-hosting-event-compulsory-license-and-access-to-medicines-the-indian-experience-to-date/
LOCATION:Wasserstein Hall Room B015\, Harvard Law School\, 1585 Massachusetts Avenue\, Cambridge\, MA\, 02138\, United States
ATTACH;FMTTYPE=image/jpeg:https://orgs.law.harvard.edu/lids/files/2013/09/wto.jpg
END:VEVENT
END:VCALENDAR